Patients switching from tirzepatide to orforglipron gained an average of 2.6 kg, compared to 9.1 kg with placebo at 24 weeks
Response of testosterone and semen parameters to a 14-week aerobic training in sedentary obese men with hyperglycaemia
We can review legitimate savings programs and safer access pathways
"The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries"
Since the glycans govern clearance, contribute to immunoassay recognition and influence bioassay potency, the two preparations can behave measurably differently even when matched by International Units
The researchers found that 137 patients (47.6%) discontinued their medication due to cost or insurance-related issues, 42 (14.6%) due to side effects, 34 (11.8%) due to shortages, 7 (2.4%) due to switching to a compounded medication, and 5 (1.7%) due to unsatisfactory weight loss